80 related articles for article (PubMed ID: 25641919)
21. CYLD: a deubiquitination enzyme with multiple roles in cancer.
Massoumi R
Future Oncol; 2011 Feb; 7(2):285-97. PubMed ID: 21345146
[TBL] [Abstract][Full Text] [Related]
22. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
23. Acute lymphoblastic leukaemia with unusual chromosomal abnormality: t(3;9) (p21;p13), del(10p12) [13].
Dhingra B; Bhargava R; Mishra P
Leuk Res; 2009 Dec; 33(12):e221-3. PubMed ID: 19476998
[TBL] [Abstract][Full Text] [Related]
24. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
[TBL] [Abstract][Full Text] [Related]
25. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
[TBL] [Abstract][Full Text] [Related]
26. A paediatric case of a TdT positive B-cell acute lymphoblastic leukaemia (B-ALL) without Burkitt characteristics.
Shende A; Festa RS; Wedgwood JF; Lanzkowsky P
Br J Haematol; 1988 Sep; 70(1):129-30. PubMed ID: 3179223
[No Abstract] [Full Text] [Related]
27. Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB.
Bastian L; Hof J; Pfau M; Fichtner I; Eckert C; Henze G; Prada J; von Stackelberg A; Seeger K; Shalapour S
Clin Cancer Res; 2013 Mar; 19(6):1445-57. PubMed ID: 23357978
[TBL] [Abstract][Full Text] [Related]
28. An emerging role of deubiquitinating enzyme cylindromatosis (CYLD) in the tubulointerstitial inflammation of IgA nephropathy.
Cui TG; Ichikawa T; Yang M; Dong X; Li J; Cui T
Biochem Biophys Res Commun; 2009 Dec; 390(2):307-12. PubMed ID: 19800320
[TBL] [Abstract][Full Text] [Related]
29. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review.
Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS
Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857
[TBL] [Abstract][Full Text] [Related]
30. Reduced expression of CYLD in human colon and hepatocellular carcinomas.
Hellerbrand C; Bumes E; Bataille F; Dietmaier W; Massoumi R; Bosserhoff AK
Carcinogenesis; 2007 Jan; 28(1):21-7. PubMed ID: 16774947
[TBL] [Abstract][Full Text] [Related]
31. An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells.
Alameda JP; Moreno-Maldonado R; Navarro M; Bravo A; Ramírez A; Page A; Jorcano JL; Fernández-Aceñero MJ; Casanova ML
Oncogene; 2010 Dec; 29(50):6522-32. PubMed ID: 20838385
[TBL] [Abstract][Full Text] [Related]
32. Loss of Smad3 in acute T-cell lymphoblastic leukemia.
Wolfraim LA; Fernandez TM; Mamura M; Fuller WL; Kumar R; Cole DE; Byfield S; Felici A; Flanders KC; Walz TM; Roberts AB; Aplan PD; Balis FM; Letterio JJ
N Engl J Med; 2004 Aug; 351(6):552-9. PubMed ID: 15295048
[TBL] [Abstract][Full Text] [Related]
33. PLAG1 and CYLD do not play a role in the tumorigenesis of adenoid cystic carcinoma.
Daa T; Nakamura I; Yada N; Arakane S; Nishida H; Kashima K; Suzuki M; Yokoyama S
Mol Med Rep; 2013 Apr; 7(4):1086-90. PubMed ID: 23404581
[TBL] [Abstract][Full Text] [Related]
34. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control.
Massoumi R; Paus R
Bioessays; 2007 Dec; 29(12):1203-14. PubMed ID: 18008375
[TBL] [Abstract][Full Text] [Related]
35. A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome.
Nagy N; Farkas K; Kinyo A; Nemeth IB; Kis E; Varga J; Bata-Csorgo Z; Kemeny L; Szell M
Exp Dermatol; 2012 Dec; 21(12):967-9. PubMed ID: 23171463
[TBL] [Abstract][Full Text] [Related]
36. Germline configuration of the p27(Kip1) gene in childhood acute lymphoblastic leukemia (ALL).
Seriu T; Erz D; Bartram CR
Leukemia; 1996 Feb; 10(2):345. PubMed ID: 8637245
[No Abstract] [Full Text] [Related]
37. Identical utilization of T-cell receptor gene regions in B-lymphoid blast crisis of chronic myeloid leukemia and B-precursor acute lymphoblastic leukemia.
di Celle PF; Carbone A; Lo Coco F; Guerrasio A; Diverio D; Rosso C; Lopez M; Saglio G; Foà R
Leukemia; 1991 May; 5(5):366-72. PubMed ID: 1827853
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia.
Jiménez-Velasco A; Román-Gómez J; Agirre X; Barrios M; Navarro G; Vázquez I; Prósper F; Torres A; Heiniger A
Leukemia; 2005 Dec; 19(12):2347-50. PubMed ID: 16208412
[No Abstract] [Full Text] [Related]
39. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations.
Huret JL; Brizard A; Slater R; Charrin C; Bertheas MF; Guilhot F; Hählen K; Kroes W; van Leeuwen E; Schoot EV
Leukemia; 1993 Feb; 7(2):152-60. PubMed ID: 8426468
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila.
Xue L; Igaki T; Kuranaga E; Kanda H; Miura M; Xu T
Dev Cell; 2007 Sep; 13(3):446-54. PubMed ID: 17765686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]